VGN-Ex05e

N/A

Report date: 2026/04/03 20:03:44

Base Information

Drug NameVGN-Ex05e
Drug Alias NameVGN-Ex05e
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Embryonic stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsAutism Spectrum Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesShanghai Vitalgen BioPharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Jiao Tong University School of MedicineShanghai Vitalgen BioPharma Co Ltd
Inactive CompaniesN/A
Active IndicationsAutism Spectrum Disorder
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A